Johnson & Johnson as of Sept. 30, 2025
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 20 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 32.3 | $163M | 2.4M | 66.43 | |
| Nanobiotix Sponsored Ads (NBTX) | 21.1 | $106M | 5.6M | 18.89 | |
| Meiragtx Holdings (MGTX) | 10.9 | $55M | 6.6M | 8.23 | |
| Rapport Therapeutics (RAPP) | 10.5 | $53M | 1.8M | 29.70 | |
| CVRX (CVRX) | 6.6 | $33M | 4.1M | 8.07 | |
| Legend Biotech Corporation Sponsored Ads (LEGN) | 5.3 | $27M | 815k | 32.61 | |
| Contineum Therapeutics Cl A (CTNM) | 4.6 | $23M | 2.0M | 11.75 | |
| Procept Biorobotics Corp (PRCT) | 2.5 | $13M | 358k | 35.69 | |
| Xencor (XNCR) | 1.7 | $8.8M | 748k | 11.73 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.7 | $8.5M | 248k | 34.49 | |
| Fate Therapeutics (FATE) | 0.8 | $4.3M | 3.4M | 1.26 | |
| Neumora Therapeutics (NMRA) | 0.7 | $3.4M | 1.8M | 1.82 | |
| Vor Biopharma | 0.5 | $2.6M | 54k | 48.72 | |
| Rallybio Corp (RLYB) | 0.4 | $1.8M | 3.6M | 0.50 | |
| Lyell Immunopharma (LYEL) | 0.1 | $669k | 41k | 16.24 | |
| Nano-X Imaging Ord Shs (NNOX) | 0.1 | $588k | 159k | 3.70 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $406k | 312k | 1.30 | |
| Adicet Bio (ACET) | 0.1 | $295k | 365k | 0.81 | |
| Chardan Healthcare Acqu- Ord | 0.0 | $51k | 97k | 0.53 | |
| Senseonics Hldgs (SENS) | 0.0 | $24k | 55k | 0.44 |
